Improving Adherence to Adjuvant Hormonal Therapy Among Disadvantaged Women Diagnosed with Breast Cancer in South Carolina: Proposal for a Multimethod Study.

ABSTRACT:

Background

Current clinical guidelines recommend that hormone receptor-positive breast cancer survivors take adjuvant hormonal therapy (AHT) for 5 to 10 years, following the end of definitive treatment. However, fewer than half of patients adhere to the guidelines, and suboptimal adherence to AHT is associated with an increased risk of breast cancer mortality. Research has extensively documented sociodemographic and disease-specific factors associated with adherence to AHT, but very little evidence exists on behavioral factors (eg, knowledge, patient-provider communication) that can be modified and targeted by interventions.

Objective

The goal of this study is to develop and test a theory-based, multilevel intervention to improve adherence to AHT among breast cancer survivor

SUBMITTER: Felder TM 

PROVIDER: S-EPMC7499167 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature